Followers | 149 |
Posts | 7615 |
Boards Moderated | 0 |
Alias Born | 01/24/2012 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, January 26, 2015 1:09:51 PM
That is what Abattis Bioceuticals is a Tech Company , as a result it should be valued based on future earnings and for me there is no doubt in my mind future revenues will be much larger than 25 million per year. The stock is valued at a fraction of what the future value of its IP should be worth, not to mention the cash on the balance sheet.
I know were long..... but I have seen stocks on the major exchanges with balance sheets that were much worse than Abattis's valued much higher than 250 million mkt. cap.......
Therefore $2.75 IMO never was out of the question nor should it be.
Long
ATTBF
Shark
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM